Patient Capital Management’s Assistant Portfolio Manager, Christina Siegel Malbon, was recently featured in Barron’s discussing how a disciplined, value-oriented approach can still uncover opportunity in today’s AI-driven market.
In the interview, Christina shared how Patient Capital evaluates businesses based on long-term intrinsic value rather than short-term market narratives. The firm’s philosophy is grounded in the belief that the value of any business is the present value of its future free cash flows. Christina highlights how this approach can support owning companies benefiting from artificial intelligence when expectations diverge from fundamentals.
We appreciate Barron’s coverage and invite you to read the full article here: AI Stocks in a Value Fund? This Veteran Money Pro Says Absolutely.
For value investors, the goal is not simply to own what looks inexpensive today. It is to identify where market prices have diverged from business fundamentals and to do so before the opportunity becomes obvious to others. That requires looking forward, assessing the durability of cash flows, and being willing to own businesses when they trade below our estimate of their long-term intrinsic value.
At Patient Capital, value investing is not about avoiding growth or innovation. It is about applying valuation discipline to both. In an AI-driven market, that perspective has been an asset.
References to specific securities are for illustrative purposes only and are not intended as a solicitation, or recommendation of any particular security or investment strategy.
Past performance is no guarantee of future results.
©2026 Patient Capital Management, LLC
Share